post-add

Lord’s Mark Industries Reports 40.41 Per cent Revenue Growth To INR 422.24 Cr In FY24

Lord’s Mark Industries has reported a robust financial performance for FY24, with revenue from operations surging by 40.41 per cent . The company's revenue increased to INR 422.24 crores, up from INR 301.08 crores in FY23, reflecting its sustained momentum in a competitive market. The company is set to go public in December 2024.

Lord’s Mark Industries has reported a robust financial performance for FY24, with revenue from operations surging by 40.41 per cent . The company's revenue increased to INR 422.24 crores, up from INR 301.08 crores in FY23, reflecting its sustained momentum in a competitive market. The company is set to go public in December 2024.

In addition to the impressive revenue growth, the company posted a remarkable 106.13 per cent  increase in Profit After Tax (PAT) for FY24, driven by strategic investments and aggressive expansion initiatives across various business segments.

Sachidanand Upadhyay, Managing Director of Lord's Mark Industries, attributed the strong financial performance to the company’s expansion in key markets and innovative product launches. "Our growth in FY24 highlights the success of our strategic investments. With the launch of electric vehicles by Lord's Automative and advanced genome testing kits and E-Smart Clinics in our medtech sector, we are tapping into the rising demand for electric vehicles and preventive healthcare," said Upadhyay. "This growth, along with our focus on process optimization and cost efficiency, positions us well for continued success in FY25 and beyond."

Lord’s Mark Industries has been focusing on its subsidiaries to develop innovative medtech products and expand its diagnostic solutions across India. The company also plans to scale up the export of its medical diagnostics products.

In FY24, the company recorded impressive growth, with revenue surging by 40.41 per cent  to INR 422.24 crores. Profit After Tax (PAT) saw an even more substantial rise of 106.13 per cent , reflecting the company’s strong financial performance. Expansion efforts have been aggressive, with a focus on establishing a presence in metro cities, as well as tier 2 and tier 3 cities, and venturing into emerging markets. The company also introduced innovative products, including electric vehicles, advanced genome testing kits, and E-Smart Clinics, further solidifying its position as a leader in the industry. 

Also Read

Subscribe to our newsletter to get updates on our latest news